Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
DNTH
DNTH News & Events
-
Add to Watchlist
Trade DNTH
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
DNTH News
Dianthus Therapeutics Shares Surge 5.6% on Positive Pipeline News
15h ago
NASDAQ.COM
Dianthus Therapeutics FDA Approves Clinical Changes for Claseprubart
6d ago
seekingalpha
5AM Venture Management Fully Exits Dianthus Therapeutics
Mar 18 2026
Fool
Dianthus Therapeutics Hits Early 'Go' in CAPTIVATE Phase 3 CIDP Trial
Mar 15 2026
Yahoo Finance
Dianthus Therapeutics (DNTH.US) Director Plans to Sell $10.55 Million in Common Stock via Form 144
Mar 12 2026
moomoo
Dianthus Therapeutics Prices $625 Million Upsized Public Offering
Mar 11 2026
NASDAQ.COM
Dianthus Therapeutics Prices Upsized $625 Million Public Offering
Mar 11 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Show More News
DNTH Events
03/11 06:10
Deal Size Increased to $625M in Common Stock
The deal size was increased to $625M in common stock from $400M in common stock. Jefferies, Evercore ISI, Stifel, Guggenheim and William Blair acted as joint book running managers for the offering.
Show More Events
DNTH Monitor News
Dianthus Therapeutics FDA Approves Changes for Claseprubart
Mar 31 2026
Dianthus Therapeutics Surges After Positive Trial Results
Mar 10 2026
Dianthus Reports Positive CAPTIVATE Trial Results Amid Earnings Miss
Mar 09 2026
DNTH Earnings Analysis
No Data
People Also Watch
